InvestorsObserver
×
News Home

Will Nautilus Biotechnology Inc (NAUT) Stay at the Top of the Healthcare Sector?

Monday, June 26, 2023 10:20 AM | InvestorsObserver Analysts

Mentioned in this article

Will Nautilus Biotechnology Inc (NAUT) Stay at the Top of the Healthcare Sector?

The 73 rating InvestorsObserver gives to Nautilus Biotechnology Inc (NAUT) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 85 percent of stocks in the Healthcare sector, NAUT’s 73 overall rating means the stock scores better than 73 of all stocks.

Overall Score - 73
NAUT has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on NAUT!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Nautilus Biotechnology Inc Stock Today?

Nautilus Biotechnology Inc (NAUT) stock has fallen -5.59% while the S&P 500 is higher by 0.25% as of 10:17 AM on Monday, Jun 26. NAUT is lower by -$0.21 from the previous closing price of $3.67 on volume of 45,493 shares. Over the past year the S&P 500 has risen 11.77% while NAUT is higher by 25.27%. NAUT lost -$0.46 per share the over the last 12 months. Click Here to get the full Stock Report for Nautilus Biotechnology Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App